Literature DB >> 24448809

[Retinal vascular diseases reflecting generalized vascular alterations. What can be mutually learnt?].

N Feltgen1, P Franko Zeitz.   

Abstract

Retinal vascular diseases are mostly caused by systemic vascular diseases. In some cases the systemic disease is already known but in other patients ocular anomalies often provide the first indications of a systemic disease. Treating patients with vascular fundus diseases requires close cooperation between ophthalmologists and specialists in other fields and deciding which routine and specialized diagnostic examinations are necessary in light of the potential risk factors involved requires interdisciplinary communication. This article aims to provide an overview of the most important vascular retinal diseases and which examinations are required to ensure an accurate diagnosis. The retinal vascular diseases with the highest frequency or clinical relevance are hypertensive retinopathy, diabetic retinopathy, retinal vein occlusion and retinal artery occlusion.

Entities:  

Mesh:

Year:  2014        PMID: 24448809     DOI: 10.1007/s00347-013-2911-1

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  29 in total

1.  Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study.

Authors:  P Gaede; P Vedel; H H Parving; O Pedersen
Journal:  Lancet       Date:  1999-02-20       Impact factor: 79.321

Review 2.  Hypertensive retinopathy.

Authors:  Tien Y Wong; Paul Mitchell
Journal:  N Engl J Med       Date:  2004-11-25       Impact factor: 91.245

3.  [Hypertensive changes of the fundus].

Authors:  W Göbel; J Matlach
Journal:  Ophthalmologe       Date:  2013-10       Impact factor: 1.059

4.  Global burden of hypertension: analysis of worldwide data.

Authors:  Patricia M Kearney; Megan Whelton; Kristi Reynolds; Paul Muntner; Paul K Whelton; Jiang He
Journal:  Lancet       Date:  2005 Jan 15-21       Impact factor: 79.321

Review 5.  [Glycemic control and cardiovascular benefit: What do we know today?].

Authors:  M Hanefeld; M Schönauer; T Forst
Journal:  Dtsch Med Wochenschr       Date:  2010-02-09       Impact factor: 0.628

6.  [Fundus hypertonicus Okulare Veranderungen bei systemischen Erkrankungen].

Authors:  U E K Schnurrbusch; S Wolf
Journal:  Ophthalmologe       Date:  2005-03       Impact factor: 1.059

7.  Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus.

Authors: 
Journal:  JAMA       Date:  2002-05-15       Impact factor: 56.272

Review 8.  Overview of epidemiologic studies of diabetic retinopathy.

Authors:  Barbara Eden Kobrin Klein
Journal:  Ophthalmic Epidemiol       Date:  2007 Jul-Aug       Impact factor: 1.648

9.  2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension.

Authors: 
Journal:  J Hypertens       Date:  2013-10       Impact factor: 4.844

10.  Effects of visit-to-visit variability in systolic blood pressure on macrovascular and microvascular complications in patients with type 2 diabetes mellitus: the ADVANCE trial.

Authors:  Jun Hata; Hisatomi Arima; Peter M Rothwell; Mark Woodward; Sophia Zoungas; Craig Anderson; Anushka Patel; Bruce Neal; Paul Glasziou; Pavel Hamet; Giuseppe Mancia; Neil Poulter; Bryan Williams; Stephen Macmahon; John Chalmers
Journal:  Circulation       Date:  2013-08-07       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.